DCTN4, dynactin subunit 4, 51164

N. diseases: 253; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0032460
Disease: Polycystic Ovary Syndrome
Polycystic Ovary Syndrome
0.010 AlteredExpression disease BEFREE Similarly, SOR also enhanced the expression of LC3-II and Caspase-3 in PCOS while substantially reducing the level of mTORC2 and P62. 31256441 2020
CUI: C0158266
Disease: Intervertebral Disc Degeneration
Intervertebral Disc Degeneration
0.010 Biomarker disease BEFREE However, p62 increased progressively with increasing disc degeneration grade. 31802633 2020
CUI: C0740457
Disease: Malignant neoplasm of kidney
Malignant neoplasm of kidney
0.010 Biomarker disease BEFREE We identify that TBK1 phosphorylates p62/SQSTM1 on Ser366 which is essential for p62 stability and kidney cancer cell proliferation. 31810986 2020
CUI: C1378703
Disease: Renal carcinoma
Renal carcinoma
0.010 Biomarker disease BEFREE We identify that TBK1 phosphorylates p62/SQSTM1 on Ser366 which is essential for p62 stability and kidney cancer cell proliferation. 31810986 2020
CUI: C0007107
Disease: Malignant neoplasm of larynx
Malignant neoplasm of larynx
0.010 Biomarker disease BEFREE Overall, our results suggest that i) cytoplasmic p62 and PTOV1 can be considered prognostic markers in laryngeal cancer, ii) the acquisition of resistance seems to be related to PTOV1 and autophagy-related protein overexpression, iii) by increasing autophagy, PTOV1 might contribute to resistance in this model and iv) the expression of autophagy-related proteins could classify a subgroup of laryngeal cancer patients who will benefit from a therapy based upon autophagy inhibition. 31050705 2019
CUI: C0013080
Disease: Down Syndrome
Down Syndrome
0.010 Biomarker disease BEFREE This conclusion was further supported by the observation that over-expression of either STX17 or VAMP8 in DS fibroblasts restored autophagic degradation and reversed p62 accumulation. 31714914 2019
CUI: C0019159
Disease: Hepatitis A
Hepatitis A
0.010 AlteredExpression disease BEFREE Results showed that DHAV infection increased the expression level of LC3-II and interdicted the degradation of p62. 30658794 2019
CUI: C0019187
Disease: Hepatitis, Alcoholic
Hepatitis, Alcoholic
0.010 AlteredExpression disease BEFREE We found impaired autophagy both in ALD and alcoholic hepatitis (AH) mouse models and human livers with ALD as indicated by increased hepatic p62 and LC3-II levels. 31090940 2019
CUI: C0023418
Disease: leukemia
leukemia
0.010 Biomarker disease BEFREE Loss of p62 impaired expansion and colony-forming ability of leukemia cells and prolonged latency of leukemia development in mice. 30498063 2019
CUI: C0023467
Disease: Leukemia, Myelocytic, Acute
Leukemia, Myelocytic, Acute
0.010 AlteredExpression disease BEFREE High p62 expression was associated with poor prognosis in human AML. 30498063 2019
Leukoencephalopathy, Progressive Multifocal
0.010 Biomarker disease BEFREE Mechanistically, XPO1 inhibition induces relocalization of autophagy adaptor protein p62 (SQSTM1), recruiting p53 for activation in PML nuclear bodies. 31088931 2019
CUI: C0027962
Disease: Melanocytic nevus
Melanocytic nevus
0.010 Biomarker disease BEFREE Immunohistochemistry for CD271 and p62 was performed on human naevi and primary malignant melanoma tumours. 30339727 2019
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.010 AlteredExpression disease BEFREE In addition, the effect of intra-articularly injected WY14643 on articular cartilage in a mouse OA model established by the destabilization of the medial meniscus was assessed using the Osteoarthritis Research Society International (OARSI) histopathology assessment system, along with the detection of Aggrecan, ADAMTS5, LC3B and P62 protein levels using immunohistochemistry assay. 30729704 2019
CUI: C0029453
Disease: Osteopenia
Osteopenia
0.010 Biomarker disease BEFREE Interestingly, p62 deficiency provoked accelerated osteopenia and impaired niche operational activities within the bone marrow. 30740681 2019
CUI: C0031099
Disease: Periodontitis
Periodontitis
0.010 AlteredExpression disease BEFREE Intriguingly, autophagy markers LC3B and P62 were upregulated in the pulp obtained from teeth with periodontitis. 31161648 2019
Gastrointestinal tract vascular insufficiency
0.010 AlteredExpression disease BEFREE Chiu's score, intestinal mucosal wet-to-dry ratio, lactic acid level, malondialdehyde level, autophagosomes, and LC3-II/LC3-I were significantly increased, and superoxide dismutase level and expression of p62 were significantly decreased in intestinal mucosa after intestinal ischemia/reperfusion. 31277013 2019
CUI: C0162309
Disease: Adrenoleukodystrophy
Adrenoleukodystrophy
0.010 AlteredExpression disease BEFREE We found impaired autophagy both in ALD and alcoholic hepatitis (AH) mouse models and human livers with ALD as indicated by increased hepatic p62 and LC3-II levels. 31090940 2019
CUI: C0162557
Disease: Liver Failure, Acute
Liver Failure, Acute
0.010 AlteredExpression disease BEFREE ACY1215 could induce autophagy in ALF mice and cell model group accompanied with an increase in expression of LC3-II and beclin-1 proteins and down-regulation of p62 protein. 31634464 2019
CUI: C0221292
Disease: Basophilic leukemia
Basophilic leukemia
0.010 Biomarker disease BEFREE Transmission electron microscopy showed p62 within extracellular vesicles of antigen-stimulated rat basophilic leukemia cells (RBL2H3). 31024564 2019
CUI: C0521858
Disease: Decreased drug resistance
Decreased drug resistance
0.010 AlteredExpression phenotype BEFREE In addition, it was identified that CLDN1 silencing decreased drug resistance by inhibiting autophagy, which was associated with a decrease in the ratio of microtubule-associated protein 1A/1B-light chain 3 (LC3)-II/LC3-I and upregulation of P62. 31788043 2019
CUI: C0595989
Disease: Carcinoma of larynx
Carcinoma of larynx
0.010 Biomarker disease BEFREE Overall, our results suggest that i) cytoplasmic p62 and PTOV1 can be considered prognostic markers in laryngeal cancer, ii) the acquisition of resistance seems to be related to PTOV1 and autophagy-related protein overexpression, iii) by increasing autophagy, PTOV1 might contribute to resistance in this model and iv) the expression of autophagy-related proteins could classify a subgroup of laryngeal cancer patients who will benefit from a therapy based upon autophagy inhibition. 31050705 2019
CUI: C0740447
Disease: Diabetic peripheral neuropathy
Diabetic peripheral neuropathy
0.010 AlteredExpression disease BEFREE Taken together, our findings demonstrate that hyperglycemia inhibits LC3-II/LC3-I in an HDAC1-Atg3-dependent manner and decreases P62 expression in an HDAC-independent manner <i>via</i> the JAK-STAT3 signaling pathway in the Schwann cells of DPN.-Du, W., Wang, N., Li, F. Jia, K., An, J., Liu, Y., Wang, Y., Zhu, L., Zhao, S. Hao, J. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy. 30913399 2019
CUI: C0752304
Disease: Hypoxic-Ischemic Encephalopathy
Hypoxic-Ischemic Encephalopathy
0.010 Biomarker disease BEFREE Expression of the p62 sequestosome 1 (P62/SQSTM1) protein, p-ERK/ERK, phospho-mammalian target of rapamycin (p-mTOR) and phospho-p70S6 were increased in SPC-HIBI group. 30460641 2019
CUI: C0872084
Disease: Sarcopenia
Sarcopenia
0.010 Biomarker phenotype BEFREE Studies in experimental animals and in patients demonstrate that ammonia is directly implicated in the pathogenesis of sarcopenia in cirrhosis via mechanisms involving increased expression of myostatin and of autophagy markers such as LC3 lipidation and p62 leading to muscle dysmetabolism and sarcopenia. 31183339 2019
CUI: C1318485
Disease: Liver regeneration disorder
Liver regeneration disorder
0.010 AlteredExpression phenotype BEFREE These findings suggest that accumulation of p62 due to loss of Ctsl plays an important role in liver regeneration through activation of Nrf2-Notch1 signaling. 30797017 2019